Oral oncology
Exercise and quality of life in head and neck squamous cell carcinoma patients receiving neoadjuvant immuno-chemotherapy: A randomized, open-labeled phase II trial.
Guoming Xiao, Li Ning, Lihui Chen, Shu Zhang, Yingle Chen, Yanfeng Chen
Published: 202510.1016/j.oraloncology.2025.107844
Abstract
BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) significantly impairs patients' quality of life (QoL). While neoadjuvant immuno-chemotherapy offers potential survival benefits, it is associated with substantial treatment-related toxicities,…
Preview only. Read the full abstract at the source